Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
belimumab b-cell-activating factor NA Successful target TTD , DGIDB Lupus Erythematosus
Systemic[MeSHID:D008180]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 63.65 approved antibody
belimumab b-cell-activating factor NA Successful target TTD , DGIDB Lupus Erythematosus
Systemic[MeSHID:D008180]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 63.65 approved unknown
belimumab tumor necrosis factor ligand superfamily member 13b biotech NA drugbank , DGIDB Lupus Erythematosus
Systemic[MeSHID:D008180]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 63.65 approved neutralizer
belimumab tumor necrosis factor ligand superfamily member 13b biotech NA drugbank , DGIDB Lupus Erythematosus
Systemic[MeSHID:D008180]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 63.65 approved neutralizer,antibody
belimumab tumor necrosis factor ligand superfamily member 13b biotech NA drugbank , DGIDB Lupus Erythematosus
Systemic[MeSHID:D008180]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 63.65 approved neutralizer,inhibitor
belimumab b-cell-activating factor NA Successful target TTD , DGIDB Lupus Erythematosus
Systemic[MeSHID:D008180]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 63.65 approved inhibitor
click here to return to the previous page